<DOC>
	<DOCNO>NCT00675207</DOCNO>
	<brief_summary>The purpose study compare efficacy brimonidine Purite , dorzolamide , brinzolamide reduce intraocular pressure add prostaglandin analog therapy ( bimatoprost , latanoprost , travoprost ) patient glaucoma ocular hypertension .</brief_summary>
	<brief_title>Comparison Brimonidine Purite , Dorzolamide , Brinzolamide Adjunctive Therapy Prostaglandin Analogs</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis primary openangle glaucoma ocular hypertension . Must 40 year age . Intraocular pressure must 18 mm Hg high 6 week treatment ( runin ) prostaglandin analog ( bimatoprost , latanoprost , travoprost ) . History angle closure narrow angle . Previous intraocular surgery . Laser trabeculoplasty within 3 month prior screen . History uveitis intraocular inflammation . Use medication study medication know affect IOP ( e.g. , betablockers , steroid , angiotensin II blocker ) within 3 month study entry study . Intolerance hypersensitivity prostaglandin analog , sulfonamide , alphaagonists , preservative benzalkonium chloride . Women childbearing age pregnant use contraception .</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>ocular hypertension</keyword>
	<keyword>adjunctive treatment</keyword>
	<keyword>prostaglandin</keyword>
	<keyword>prostaglandin analog</keyword>
	<keyword>brimonidine</keyword>
	<keyword>dorzolamide</keyword>
	<keyword>brinzolamide</keyword>
	<keyword>alpha agonist</keyword>
	<keyword>carbonic anhydrase inhibitor</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>